09Jun 2023
Management of oral herpes simplex virus infections: The problem of resistance. A narrative review

Management of oral herpes simplex virus infections: The problem of resistance. A narrative review

Herpes Simplex Virus (HSV) type 1 and type 2 are common viral infections that affect billions of people worldwide. While HSV infections are typically mild and self-limiting in healthy individuals, they can be more severe and life-threatening in immunocompromised patients. Acyclovir and its derivatives are the standard antiviral drugs for HSV treatment, but drug resistance can occur, especially in immunocompromised patients, leading to serious complications. This review examines alternative treatment options for acyclovir-resistant HSV infections, focusing on studies published between 1989 and 2022. Cidofovir and foscarnet are potential alternatives for these cases. The development of new antiviral drugs and vaccines may help address drug resistance in the future.

  • #dentistry

Like

Save

Share